Passage Bio, Inc.
PASG
Last
$3.69
Day
-1.1%
1y
-56.5%
5y
-98.1%
52w
-81.1%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-0929d
EMA 21
4.36
EMA 50
4.60
EMA 200
6.18
20d high
-25.5%
5y high
-98.2%
5y range
0th
Positions held
Your positionsPASG isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-24
Hold
avoid
Signal
Strong Sell
Target
$4.30
Stop
$3.35
Stop distance
9.2%
Target vs last
+16.5%
Fundamentals
| Market cap | $12.16M | Enterprise value | -$11.99M | Trailing P/E | — | Forward P/E | -0.36 |
| PEG | — | Price / book | 2.73 | Beta | 1.39 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -1.7% | ROA | -45.6% | Debt / equity | — |
| Current ratio | 1.22 | Free cash flow | -$14.81M | Analyst recommendation | buy | Mean target | $15.50 |
| 52w high | $20.00 | 52w low | $3.29 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$7.8M | -$7.6M | -$13.0M | -$7.7M | -$9.4M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$10.2M | -$8.9M | -$10.3M | -$8.7M | -$10.3M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$45.5M | -$64.8M | -$102M | -$136M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$43.2M | -$65.2M | -$103M | -$135M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
No headlines.
Price (daily)
Full chart · RSI · MACD · patternsPASG · daily-23.6% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin